Mindfulness-based Psilocybin Therapy for PTSD | MicrobiomeTrials← Back to trialsNCT07104916
Mindfulness-based Psilocybin Therapy for PTSD
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2029-09
Enrollment target: 30 participants Locations- The Ohio State University Medical Center, Columbus, Ohio, United States
Other microbiome trials you might be interested in
Obsessive-Compulsive DisorderPost Traumatic Stress DisorderGeneralized Anxiety DisorderSocial Anxiety DisorderPanic Disorder
Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. T…
Boston, United StatesEst. completion Dec 1, 2026
Acute Respiratory Distress Syndrome (ARDS)s100bMechanical PowerVentilator Induced Lung InjuryTranspulmonary Pressure
Acute respiratory distress syndrome (ARDS) is characterized by pathological pulmonary edema caused by direct or indirect…
Multiple LocationsEst. completion Oct 23, 2028